v3.25.2
Stockholders' Deficit (Tables)
3 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Stockholders’ Deficit [Abstract]    
Schedule of Shares of Common Stock are Reserved for Future Issuance The following shares of common stock are reserved for future issuance:
Convertible notes payable   480,608 
Stock options issued and outstanding   104,823 
Stock purchase warrants   5,381,916 
    5,967,347 
The following shares of common stock are reserved for future issuance:
Convertible notes payable   464,217 
Stock options issued and outstanding under Old Nukk equity incentive plan   4,823 
Stock purchase warrants   5,465,249 
    5,934,289 
Schedule of Shares of Common Stock Issuable upon Exercise of Warrants Outstanding

The following table summarizes the shares of the Company’s common stock issuable upon exercise of warrants outstanding at March 31, 2025:

 

   Warrants Outstanding 
   Range of
Exercise
Price
   Number
Outstanding at
March 31,
2025
   Weighted
Average
Remaining
Contractual
Life (Years)
   Weighted
Average
Exercise
Price
 
Public and Private Warrants  $92.00    837,625    0.58   $14.32 
April 2024 Warrants   6.88    14,535    0.01    0.02 
June 2024 Warrants   2.00    150,000    0.12    0.06 
August 2024 Warrants   2.00    175,000    0.14    0.07 
November 2024 Warrant   2.41    351,424    0.30    0.16 
Pre-funded Warrants   0.0001    1,353,333    1.18    0.00 
Private Placement Warrant   6.00    2,499,999    2.19    2.79 
    $0.0001 – 92.00    5,381,916    4.52   $17.42 

 

The following table summarizes the shares of the Company’s common stock issuable upon exercise of warrants outstanding at December 31, 2024:

 

   Warrants Outstanding 
   Range of
Exercise
Price
   Number
Outstanding at
December 31,
2024
   Weighted
Average
Remaining
Contractual
Life (Years)
   Weighted
Average
Exercise
Price
 
Public and Private Warrants  $92.00    837,625    0.61   $14.10 
April 2024 Warrants   6.88    14,535    0.01    0.02 
June 2024 Warrants   2.00    150,000    0.12    0.05 
August 2024 Warrants   2.00    175,000    0.15    0.06 
November 2024 Warrant   2.41    351,424    0.31    0.15 
Pre-funded Warrants   0.0001    1,436,666    1.30    0.00 
Private Placement Warrant   6.00    2,499,999    2.27    2.74 
    $0.0001 – 92.00    5,465,249    4.77   $17.12 

The following table summarizes the shares of the Company’s common stock issuable upon exercise of warrants outstanding at December 31, 2024:

 

   Warrants Outstanding 
   Range of
Exercise
Price
   Number
Outstanding at
December 31,
2024
   Weighted
Average
Remaining
Contractual
Life
(Years)
   Weighted
Average
Exercise
Price
 
Public and Private Warrants  $92.00    837,625    0.61   $14.10 
April 2024 Warrants   6.88    14,535    0.01    0.02 
June 2024 Warrants   2.00    150,000    0.12    0.05 
August 2024 Warrants   2.00    175,000    0.15    0.06 
November 2024 Warrant   2.41    351,424    0.31    0.15 
Pre-funded Warrants   0.0001    1,436,666    1.30    0.00 
Private Placement Warrant   6.00    2,499,999    2.27    2.74 
   $0.0001 – 92.00    5,465,249    4.77   $17.12 

 

The following table summarizes the shares of the Company’s common stock issuable upon exercise of warrants outstanding at September 30, 2024:

 

   Warrants Outstanding 
   Range of
Exercise
Price
   Number
Outstanding at
September 30,
2024
   Weighted
Average
Remaining
Contractual
Life
(Years)
   Weighted
Average
Exercise
Price
 
Public and Private Warrant  $92.00    837,625    3.02   $65.46 
April 2024 Warrant   6.88    14,535    0.03    0.08 
June 2024 Warrant   2.00    150,000    0.61    0.25 
August 2024 Warrant   2.00    175,000    0.72    0.30 
   $2.00 – 92.00    1,177,160    4.38   $66.09 
Schedule of Warrant Activities

Warrant activities for the three months ended March 31, 2025 were as follows:

 

   Number of
Options
   Weighted
Average
Exercise
Price
 
Outstanding at December 31, 2024   5,465,249    17.12 
Exercised   (83,333)   
-
 
Outstanding at March 31, 2025   5,381,916   $17.42 

Warrant activities for the three months ended December 31, 2024 and the years ended September 30, 2024 and 2023 were as follows:

 

   Number of
Options
   Weighted
Average
Exercise
Price
 
Outstanding at September 30, 2022   837,625   $92.00 
Issued   
    
 
Outstanding at September 30, 2023   837,625    92.00 
Issued   339,535    2.21 
Outstanding at September 30, 2024   1,177,160    66.10 
Issued   2,851,423    4.83 
Outstanding at December 31, 2024   4,028,583   $22.73 
Schedule of Issued Shares of Common Stock Consideration for Services Rendered Valued at Fair Market Value on the Grant  

During the three months ended December 31, 2024, the Company issued shares of its common stock to settle obligations to vendors at fair value on the grant dates using the reported closing share price on the dates of grant as follows:

 

   Common
stock shares
   Fair value   Carrying
value
obligation
   Gain (loss) on
extinguishment
 
October 2024   100,000   $200,000   $140,000   $(60,000)
November 2024   254,660    559,993    392,000    (167,993)
    354,660   $759,993   $532,000   $(227,993)

During the year ended September 30, 2024, the Company issued shares of its common stock to settle obligations to vendors were valued at fair value on the grant dates using the reported closing share prices on the dates of grant as follows:

 

   Common
stock shares
   Fair value   Carrying
value
obligation
   Gain (loss) on
extinguishment
 
January 2024   25,338   $750,000   $750,000   $
 
May 2024   87,500    501,000    324,601    (176,399)
July 2024   148,694    374,788    262,352    (112,436)
July 2024   37,500    95,400    252,000    156,600 
July 2024   37,500    95,400    150,000    54,600 
July 2024   25,000    63,600    63,600    
 
    361,532   $1,880,188   $1,802,553   $(77,635)